✦ HHS has moved ahead with its plan to eliminate rebates to PBMs and plans in Medicare Part D. The administration issued a final rule (85 Fed. Reg. 76666, Nov. 30, 2020) providing safe harbor to rebates given to beneficiaries at the point of sale and to certain PBM service fees. The move follows a proposed rule initially released Jan. 31, 2019 (RSP 2/19, p. 1). The final rule pushed back the implementation date from Jan. 1, 2020, to Jan. 1, 2022. View the rule at https://bit.ly/3gxs6Q3.
✦ Specialty drugs represented 48.5% of net costs in Medicaid in 2019 but accounted for only 1.3% of utilization, according to Magellan Rx Management’s fifth annual Medicaid Pharmacy Trend Report. Specialty trend mainly was driven by net cost per claim, which rose from 2018 by $141.12, while specialty drug utilization declined 0.9%. The report projects that specialty drugs will make up half of overall Medicaid net spend in 2020. Download the report at https://bit.ly/3mZKkvR.